×

- Serial transient elastography examinations to monitor patients with type 2 diabetes: A prospective cohort study. Hepatology. 2020 Jan 28. [Epub ahead of print]

- Unresolved issues of immune tolerance in chronic hepatitis B. J Gastroenterol. 2020 Feb 3. [Epub ahead of print]

- Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study. Dig Dis Sci. 2020 Feb 13. [Epub ahead of print]

- Factors associated with improvement in MELD score after antiviral treatment in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2020 Feb 7. [Epub ahead of print]

- Long-Term Outcomes of Antiviral Therapy in Patients with Advanced Chronic HBV Infection. Clin Gastroenterol Hepatol. 2019 Dec;17(13):2811-2813

- Progression of Untreated Minimally Active Chronic HBV Infection Compared with Inactive Infection. Clin Gastroenterol Hepatol. 2019 Dec;17(13):2808-2810.

- Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy. Sci Rep. 2019 Nov 21;9(1):17518.

- Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin in Treatment of Chronic HBV infection. Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31089-4.

- External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy. Liver Int. 2019 Sep;39(9):1624-1630

- Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison with Virological Responders by Antivirals. Clin Transl Gastroenterol. 2019 Jun;10(6):e00036.

- Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals. Sci Rep. 2019 Feb 21;9(1):2508

- Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-resistant Chronic HBV infection. Clin Gastroenterol Hepatol. 2018 Oct 26

- Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib. Liver Int. 2018 Sep;38(9):1655-1663.

- Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety. Gut Liver. 2018 May 15;12(3):324-330

- Effect of S267F variant of NTCP on the patients with chronic hepatitis B. Sci Rep. 2017 Dec 15;7(1):17634

- The relationship between visceral obesity and hepatic steatosis measured by controlled attenuation parameter. PLoS One. 2017 Oct 27

- Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B. Liver Int. 2017 Sep 2.

- Survival Estimates after Stopping Sorafenib in Patients with Hepatocellular Carcinoma: NEXT Score Development and Validation. Gut Liver. 2017 Jun 27.

- Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection, Oncology. 2017 Jun 2.

- Prevalence and Predictors of Significant Fibrosis among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2017 May 18.

- Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis. Hepatol Int. 2017 Feb 21.

- Red cell volume distribution width-to-platelet ratio in assessment of liver fibrosis in patients with chronic hepatitis, Liver Int. 2016 Jan;36(1):24-3

- Predicting liver-related events using transient elastogrpahy in chronic hepatitis C patients with SVR, Gut Liver. 2015 Sep 9. doi: 10.5009/gnl15021. [Epub ahead of print]